$16.97
0.71% today
NYSE, Dec 24, 07:10 pm CET
ISIN
US58470H1014
Symbol
MED

Medifast Inc Target price 2024 - Analyst rating & recommendation

Medifast Inc Classifications & Recommendation:

Hold
100%

Medifast Inc Price Target

Target Price $16.50
Price $16.85
Deviation
Number of Estimates 2
2 Analysts have issued a price target Medifast Inc 2025 . The average Medifast Inc target price is $16.50. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 2 analysts: 0 Analysts recommend Medifast Inc to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medifast Inc stock has an average upside potential 2025 of . Most analysts recommend the Medifast Inc stock at Hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 1,072.05 597.70
32.94% 44.25%
EBITDA Margin 13.44% 6.89%
7.80% 48.75%
Net Margin 9.29% -0.07%
6.59% 100.75%

2 Analysts have issued a sales forecast Medifast Inc 2024 . The average Medifast Inc sales estimate is

$598m
Unlock
. This is
11.38% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$603m 10.58%
Unlock
, the lowest is
$592m 12.18%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $1.1b 32.94%
2024
$598m 44.25%
Unlock
2025
$510m 14.70%
Unlock
2026
$509m 0.13%
Unlock

2 Analysts have issued an Medifast Inc EBITDA forecast 2024. The average Medifast Inc EBITDA estimate is

$41.2m
Unlock
. This is
59.07% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$42.7m 64.86%
Unlock
, the lowest is
$39.7m 53.28%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $144m 38.17%
2024
$41.2m 71.41%
Unlock
2025
$17.2m 58.25%
Unlock
2026
$23.7m 37.79%
Unlock

EBITDA Margin

2023 13.44% 7.80%
2024
6.89% 48.75%
Unlock
2025
3.37% 51.09%
Unlock
2026
4.65% 37.98%
Unlock

2 Medifast Inc Analysts have issued a net profit forecast 2024. The average Medifast Inc net profit estimate is

$-440k
Unlock
. This is
106.00% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$220k 97.00%
Unlock
, the lowest is
$-1.1m 114.87%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $99.6m 28.52%
2024
$-440k 100.44%
Unlock
2025
$3.3m 845.45%
Unlock
2026
$5.5m 66.77%
Unlock

Net Margin

2023 9.29% 6.59%
2024
-0.07% 100.75%
Unlock
2025
0.64% 1,014.29%
Unlock
2026
1.07% 67.19%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 9.10 -0.04
28.52% 100.44%
P/E negative
EV/Sales 0.05

2 Analysts have issued a Medifast Inc forecast for earnings per share. The average Medifast Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.04
Unlock
. This is
105.97% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.02 97.01%
Unlock
, the lowest is
$-0.10 114.93%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $9.10 28.52%
2024
$-0.04 100.44%
Unlock
2025
$0.30 850.00%
Unlock
2026
$0.50 66.67%
Unlock

P/E ratio

Current 25.21 314.64%
2024
-421.25 1,770.96%
Unlock
2025
56.17 113.33%
Unlock
2026
33.70 40.00%
Unlock

Based on analysts' sales estimates for 2024, the Medifast Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.05 89.58%
2024
0.05 7.00%
Unlock
2025
0.06 17.20%
Unlock
2026
0.06 0.16%
Unlock

P/S ratio

Current 0.27 54.16%
2024
0.31 12.85%
Unlock
2025
0.36 17.26%
Unlock
2026
0.36 0.11%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today